How To Manage Myasthenia Gravis

Intravenous Immunoglobulin

Intravenous immunoglobulin (IVIG) is a therapy that provides the body with some normal antibodies, which can help with many conditions, including myasthenia gravis. This therapy has a lower side effect risk than several other therapies, but there are some potential drawbacks as well. With plasmapheresis, the effects are felt as soon as the treatment is over, but with intravenous immunoglobulin, it's about a week before results begin to show. Benefits don't tend to last longer than between three and six weeks, and the side effects tend to be mild and include fluid retention, headaches, dizziness, and chills.

IVIG is a product created from a serum distilled from one to fifteen thousand donors. In addition to being used to help with myasthenia gravis, IVIG helps patients suffering from other antibody deficiencies. A human's plasma has several core components, one of which is immunoglobulin. By using the immunoglobulin of healthy donors, IVIG safely introduces normal antibodies to patients with antibody-centric illnesses.

Continue reading to learn more about treating myasthenia now.